Lidocaine Hydrochloride Solution
FDA Label NDC 71351-026

59 label sections · Submitted to the FDA by Brookfield Pharmaceuticals, Llc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Brookfield Pharmaceuticals, Llc. for the product Lidocaine Hydrochloride (NDC 71351-026). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding highlights of prescribing information, table of content, 1 indications and usage, 2 dosage and administration, 2.1 important dosage and administration information, 2.2 recommended dosages of lidocaine hydrochloride injection, usp in adults, 2.3 use in epidural anesthesia, 2.4 test dose for epidural blocks, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.